Long-term assessment of the Ross procedure in adults: Clinical and echocardiographic follow-up at 20 years.

INTRODUCTION: The Ross procedure is an alternative to standard aortic valve (AV) replacement in young and middle-aged patients. However, durability and incidence of reoperation remain a concern for most cardiac surgeons. Our aim was to assess very long-term clinical and echocardiographic outcomes of the Ross procedure. METHODS: We conducted a single-center retrospective analysis of 56 consecutive adult patients who underwent the Ross procedure. Mean age at surgery was 44±12 years (range, 16-65 years) and 55% were male. Clinical endpoints included overall mortality and the need for valve reoperation due to graft failure. The echocardiographic endpoint was the presence of any graft deterioration. Median clinical follow-up was 20 years (1120 patient/years). RESULTS: Indications for surgery were dominant aortic stenosis in 50% and isolated aortic regurgitation in 21%. Concomitant mitral valve repair was performed in 21% and a subcoronary technique was most commonly used (86%). Overall long-term survival was 91%, 80% and 77% at 15, 20 and 24 years, respectively. The survival rate was similar to the age- and gender-matched general population (p=0.44). During the follow-up period, freedom from graft reoperation was 80%. Eleven patients (31%) developed moderate AV regurgitation, three (8.6%) developed moderate pulmonary regurgitation and one (2.9%) presented moderate pulmonary stenosis. CONCLUSION: The Ross procedure, mostly using a subcoronary approach, proved to have good clinical and hemodynamic results, with low reoperation rates in long-term follow-up. Moderate autograft regurgitation was a frequent finding but had no significant clinical impact.

Benchmarking clinical practice in surgery: looking beyond traditional mortality rates.

This paper proposes two new measures to assess performance of surgical practice based on observed mortality: reliability, measured as the area under the ROC curve and a living score, the sum of individual risk among surviving patients, divided by the total number of patients. A Monte Carlo simulation of surgeons' practice was used for conceptual validation and an analysis of a real-world hospital department was used for managerial validation. We modelled surgical practice as a bivariate distribution function of risk and final state. We sampled 250 distributions, varying the maximum risk each surgeon faced, the distribution of risk among dead patients, the mortality rate and the number of surgeries performed yearly. We applied the measures developed to a Portuguese cardiothoracic department. We found that the joint use of the reliability and living score measures overcomes the limitations of risk adjusted mortality rates, as it enables a different valuation of deaths, according to their risk levels. Reliability favours surgeons with casualties, predominantly, in high values of risk and penalizes surgeons with deaths in relatively low levels of risk. The living score is positively influenced by the maximum risk for which a surgeon yields surviving patients. These measures enable a deeper understanding of surgical practice and, as risk adjusted mortality rates, they rely only on mortality and risk scores data. The case study revealed that the performance of the department analysed could be improved with enhanced policies of risk management, involving the assignment of surgeries based on surgeon's reliability and living score.

[A rare case of two mechanisms of prosthetic valve dysfunction in the same patient]. / Um caso raro de dois mecanismos de disfunção protésica no mesmo doente.

Prosthetic valve dysfunction is a significant clinical event. Determining its etiological mechanism and severity can be difficult. The authors present the case of a 50-year-old man, with two mechanical valve prostheses in aortic and mitral positions, hospitalized for decompensated heart failure. He had a long history of rheumatic multivalvular disease and had undergone three heart surgeries. On admission, investigation led to a diagnosis of severe dysfunction of both mechanical prostheses with different etiologies and mechanisms: pannus formation in the prosthetic aortic valve and intermittent dysfunction of the mitral prosthesis due to interference of a ruptured chorda tendinea in closure of the disks. The patient was reoperated, leading to significant improvement in functional class.

[Diagnosis, prevention and treatment of cardiac allograft vasculopathy]. / Diagnóstico, prevenção e tratamento da doença vascular do aloenxerto.

The major limitation of long-term survival after cardiac transplantation is allograft vasculopathy, which consists of concentric and diffuse intimal hyperplasia. The disease still has a significant incidence, estimated at 30% five years after cardiac transplantation. It is a clinically silent disease and so diagnosis is a challenge. Coronary angiography supplemented by intravascular ultrasound is the most sensitive diagnostic method. However, new non-invasive diagnostic techniques are likely to be clinically relevant in the future. The earliest possible diagnosis is essential to prevent progression of the disease and to improve its prognosis. A new nomenclature for allograft vasculopathy has been published in July 2010, developed by the International Society for Heart and Lung Transplantation (ISHLT), establishing a standardized definition. Simultaneously, the ISHLT published new guidelines standardizing the diagnosis and management of cardiac transplant patients. This paper reviews contemporary concepts in the pathophysiology, diagnosis, prevention and treatment of allograft vasculopathy, highlighting areas that are the subject of ongoing research.

Serum creatinine values underestimate surgical risk.

INTRODUCTION: Renal insufficiency is associated with increased mortality and morbidity from cardiac surgery. Serum creatinine (SCr) values are routinely used for the assessment of renal dysfunction. However, this parameter can overestimate renal function, especially in low-weight and elderly patients, who can have normal creatinine values despite impaired renal function. OBJECTIVE: 1) To evaluate the prevalence and prognostic impact of different degrees of preoperative renal dysfunction (RD); 2) to assess the prevalence of normal SCr values among patients in different stages of RD. METHODS: This was a retrospective study of 1314 consecutive adult patients (836 male, mean age 66 +/- 11 years) undergoing cardiac surgery. Patients were assigned to one of the five stages of RD of the National Kidney Foundation classification according to their glomerular filtration rate (GFR), estimated by the Cockcroft-Gault equation and indexed to body surface area. The impact of each stage of RD on in-hospital mortality was assessed after adjusting for all the other EuroSCORE components in multivariate analysis. RESULTS: The median logistic EuroSCORE was 3.8 (interquartile range: 1.9-7.0). In-hospital mortality was 3.4% (n = 35). The prevalence of stages 3, 4 and 5 RD was 30.2% (n = 397), 3.4% (n = 45) and 4.3% (n = 56) respectively. Increasing in-hospital mortality was observed across ascending stages of RD. After adjustment for other EuroSCORE risk factors. stage 3 or higher RD was an independent predictor of in hospital mortality--OR 2.0 (95% CI: 1.1-3.9, p = 0.03). Among patients with stage 3 or higher RD, 61% (n = 304) had SCr values < 1.50 mg/dl and 83% (n = 414) had SCr < 2.26 mg/dl (the EuroSCORE cutoff value). CONCLUSIONS: Renal impairment is common among patients undergoing cardiac surgery and the presence of even mild forms of RD is associated with increased mortality. SCr values within the normal range frequently correspond to moderate or even severe RD, indicating that GFR should be calculated systematically to avoid underestimation of surgical risk.

Coronary sinus pacing in a patient with a tricuspid prosthesis.

We present images of a permanent pacing lead implanted in the coronary sinus of a patient with a tricuspid prosthesis.

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

BACKGROUND: The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. METHODS AND RESULTS: Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P<0.0001). Diabetes (P<0.0009) and maximal pressure for stent deployment (P<0.002) are the strongest independent predictors of events at 3 years after PCI, whereas left anterior descending coronary artery grafting (P<0.006) is the best predictor of event-free survival at 3 years after CABG. The incremental cost of surgery compared with PCI for an event-free patient was 19 257 at 1 year but decreased to 10 492 at 3 years. It remained at 142 391 at 3 years when revascularization procedures were excluded in the efficacy end point, however. CONCLUSIONS: Three-year survival rates without stroke and myocardial infarction are identical in both groups, and the cost/benefit ratio of stenting is determined primarily by the increasing need for revascularization in the PCI group.

Ablation of atrial fibrillation in mitral valve disease patients: five year follow-up after percutaneous pulmonary vein isolation and mitral balloon valvuloplasty.

BACKGROUND: The association between atrial fibrillation (AF) and mitral valve disease is frequent. Isolation of the pulmonary veins by radiofrequency energy applications performed intraoperatively has been proposed for patients with AF in whom mitral valve surgery has been indicated. Balloon mitral valvuloplasty is currently the preferred procedure for patients with mitral stenosis and a favorable valve anatomy. AIM: To evaluate the short- and long-term results of percutaneous pulmonary vein isolation for the treatment of AF in patients with mitral stenosis undergoing balloon mitral valvuloplasty. METHODS: Five patients (four male and one female, age 43 +/- 4 years) underwent balloon mitral valvuloplasty concomitant with pulmonary vein isolation between August 1996 and February 1997. These patients had permanent AF, diagnosed 31 +/- 12 months previously; their mitral valve area was 1.0 +/- 0.25 cm2 and their left atria measured 54 +/- 5 mm. Balloon mitral valvuloplasty was performed via a transseptal approach, and then four ablation lines were created in the left atrial posterior wall to encircle all four pulmonary veins. Radiofrequency applications lasted 45 seconds each, and aimed at a maximum preset temperature of 65 degrees C. Electrical cardioversion was performed at the end of the procedure. RESULTS: Mitral valve area increased 1.0 +/- 0.3 cm2 after valvuloplasty. The number of radiofrequency applications per patient was 37 +/- 3, and the average duration of the entire treatment was 131 +/- 28 minutes. Fluoroscopy time averaged 32 +/- 12 minutes. All patients were discharged in sinus rhythm, and mitral flow Doppler evaluation at one month showed a biphasic pattern in all cases, with the A wave measuring 70 +/- 15 cm/sec. Three patients maintained sinus rhythm at five-year follow-up. Of these patients, one had developed a left atrial flutter at four-year follow-up and underwent ablation. The remaining two patients presented AF at five year follow-up. CONCLUSIONS: Percutaneous isolation of the pulmonary veins concomitant with balloon mitral valvuloplasty had suppressed AF in 60% of patients by five-year follow-up.

Nitric oxide in the management of pulmonary hypertension in the context of cardiac surgery in the adult.

Pulmonary hypertension is a significant problem to take into account in the post-operative management of cardiac patients, especially valvular patients. Inhaled nitric oxide allows more effective control of pulmonary pressure and other hemodynamic parameters, with better post-operative results. We present a clinical case of a patient with mitral stenosis and severe pulmonary hypertension, with post-operative hemodynamic instability, in which we used inhaled nitric oxide for better control of pulmonary pressures and to help ventilator weaning.

Atrial fibrillation and effective refractory period of the pulmonary vein ostia.

BACKGROUND: The pathogenesis of atrial fibrillation (AF) is not completely understood. The role of pulmonary veins (PV) in AF initiation is documented, and the recent demonstration of persistent fibrillatory activity in an isolated PV suggests that the PV play a role in the maintenance of AF. OBJECTIVE: Since AF is facilitated by multiple reentry circuits in atrial tissue with short effective refractory periods (ERP) and prolonged conduction times, we investigated whether PV have shorter ERP compared with the left atrium (LA). POPULATION AND METHODS: The study population consisted of five male patients, between 45 and 78 years of age, with normal sized LA; three had coronary artery bypass surgery (and no previous history of atrial arrhythmias) and two had paroxysmal lone AF refractory to antiarrhythmic drugs and were referred for percutaneous ablation with radiofrequency energy. In the surgical patients, epicardial bipolar pacing wires were inserted in the PV ostia and LA roof at the end of the procedure. Post-operatively, the pacing wires were used to determine atrial thresholds and ERP in the PV ostia and LA roof. In the AF patients, atrial thresholds and ERP at these locations were obtained with the mapping/ablation catheter before and after PV isolation. ERP were determined with a basic pacing cycle length of 500 ms and a single extrastimulus with an initial coupling interval of 350 ms, gradually decreased (10 ms at a time) until atrial capture failure or AF induction. RESULTS: ERP in the LA roof were longer than 210 ms. The shortest ERP was always obtained in a PV ostium, with the shortest in the left PV ostia. The ERP values of the right inferior PV most resembled those of the LA roof. In patients referred for ablation, AF was induced when PV ostia with ERP shorter than 200 ms were stimulated. CONCLUSION: In the present study, the ERP of PV ostia were shorter than LA ERP, possibly explaining not only the presence of ectopic foci in the PV ostia, but also sustained fibrillatory activity in isolated PV, despite conversion of the atria to sinus rhythm. This fact may also explain the higher success rate and the preference for PV isolation in AF ablation.